Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Liew

Showing results (321-330 of 481) with videos related to

Pageof 49
Sort By:
European Journal of Preventive Cardiology|August 17, 2021
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveFeby Savira, Bing H Wang, Andrew R Kompa, et al.
Ecancermedicalscience|June 23, 2020
Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysisRichard Ofori-Asenso, Oyepeju Ogundipe, Akosua Adom Agyeman, et al.
The Journal of Antimicrobial Chemotherapy|June 2, 2011
Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasisChin Fen Neoh, Danny Liew, Monica Slavin, et al.
Cardiovascular Diagnosis and Therapy|July 6, 2019
Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndromeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
British Journal of Clinical Pharmacology|November 8, 2018
Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyRichard Ofori-Asenso, Jenni Ilomäki, Mark Tacey, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Long-term persistence and adherence to blood pressure lowering agents among older AustraliansSi Si, Richard Ofori-Asenso, Tom Briffa, et al.
Cardiovascular Therapeutics|August 20, 2009
Drug treatment and cost of cardiovascular disease in AustraliaZanfina Ademi, Danny Liew, Derek Chew, et al.
Journal of Clinical Lipidology|August 12, 2014
Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemiaZanfina Ademi, Gerald F Watts, Jing Pang, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2010
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemiaDaoud Al-Badriyeh, Monica Slavin, Danny Liew, et al.
Heart, Lung & Circulation|December 6, 2025
Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?Ralph G Audehm, Danny Liew, Gerald F Watts, et al.
Pageof 49

Showing results (321-330 of 481) with videos related to

Sort By:
Pageof 49
European Journal of Preventive Cardiology|August 17, 2021
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveFeby Savira, Bing H Wang, Andrew R Kompa, et al.
Ecancermedicalscience|June 23, 2020
Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysisRichard Ofori-Asenso, Oyepeju Ogundipe, Akosua Adom Agyeman, et al.
The Journal of Antimicrobial Chemotherapy|June 2, 2011
Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasisChin Fen Neoh, Danny Liew, Monica Slavin, et al.
Cardiovascular Diagnosis and Therapy|July 6, 2019
Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndromeRichard Ofori-Asenso, Ella Zomer, Ken Lee Chin, et al.
British Journal of Clinical Pharmacology|November 8, 2018
Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyRichard Ofori-Asenso, Jenni Ilomäki, Mark Tacey, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Long-term persistence and adherence to blood pressure lowering agents among older AustraliansSi Si, Richard Ofori-Asenso, Tom Briffa, et al.
Cardiovascular Therapeutics|August 20, 2009
Drug treatment and cost of cardiovascular disease in AustraliaZanfina Ademi, Danny Liew, Derek Chew, et al.
Journal of Clinical Lipidology|August 12, 2014
Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemiaZanfina Ademi, Gerald F Watts, Jing Pang, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2010
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemiaDaoud Al-Badriyeh, Monica Slavin, Danny Liew, et al.
Heart, Lung & Circulation|December 6, 2025
Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?Ralph G Audehm, Danny Liew, Gerald F Watts, et al.
Pageof 49